Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Targeted "bone-seeking" radiopharmaceuticals for palliative treatment of bone metastases: a systematic review and meta-analysis.

D'angelo G, Sciuto R, Salvatori M, Sperduti I, Mantini G, Maini CL, Mariani G.

Q J Nucl Med Mol Imaging. 2012 Dec;56(6):538-43. Review.

PMID:
23358407
2.

Radiopharmaceuticals for the palliation of painful bone metastasis-a systemic review.

Bauman G, Charette M, Reid R, Sathya J.

Radiother Oncol. 2005 Jun;75(3):258-70. Review.

PMID:
16299924
3.

Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153.

Guerra Liberal FD, Tavares AA, Tavares JM.

Appl Radiat Isot. 2016 Apr;110:87-99. doi: 10.1016/j.apradiso.2016.01.003. Epub 2016 Jan 6. Review.

PMID:
26773820
4.

Radiopharmaceutical therapy for palliation of bone pain from osseous metastases.

Pandit-Taskar N, Batraki M, Divgi CR.

J Nucl Med. 2004 Aug;45(8):1358-65. Review.

5.
6.

Cancer therapy using bone-seeking isotopes.

Lewington VJ.

Phys Med Biol. 1996 Oct;41(10):2027-42. Review.

PMID:
8912378
7.

Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement.

Kraeber-Bodéré F, Campion L, Rousseau C, Bourdin S, Chatal JF, Resche I.

Eur J Nucl Med. 2000 Oct;27(10):1487-93.

PMID:
11083537
8.

The use of radioisotopes for palliation of metastatic bone pain.

Gkialas I, Iordanidou L, Galanakis I, Giannopoulos S.

J BUON. 2008 Apr-Jun;13(2):177-83. Review.

PMID:
18555462
9.

89Sr versus 153Sm-EDTMP: comparison of treatment efficacy of painful bone metastases in prostate and breast carcinoma.

Baczyk M, Czepczyński R, Milecki P, Pisarek M, Oleksa R, Sowiński J.

Nucl Med Commun. 2007 Apr;28(4):245-50.

PMID:
17325585
11.

The correlation between palliation of bone pain by intravenous strontium-89 and external beam radiation to linked field in patients with osteoblastic bone metastases.

Ron IG, Stav O, Vishne T, Evan-Sapir E, Soyfer V, Agai R, Cherny N, Kovner F.

Am J Clin Oncol. 2004 Oct;27(5):500-4.

PMID:
15596920
12.

Teletherapy and radiopharmaceutical therapy of painful bone metastases.

Silberstein EB.

Semin Nucl Med. 2005 Apr;35(2):152-8. Review.

PMID:
15765378
13.

[Palliative treatment of metastasic bone pain].

Pons F, Fuster D, Vidal-Sicart S.

Rev Esp Med Nucl. 2003 Nov;22(6):429-38. Review. Spanish. No abstract available.

14.

Bone pain palliation with 85Sr therapy.

Giammarile F, Mognetti T, Blondet C, Desuzinges C, Chauvot P.

J Nucl Med. 1999 Apr;40(4):585-90.

15.

ESR dosimetry of 89Sr and 153Sm in bone.

Kinoshita A, Braga FJ, Graeff CF, Baffa O.

Appl Radiat Isot. 2001 Feb;54(2):269-74.

PMID:
11200888
16.

Considerations in the selection of radiopharmaceuticals for palliation of bone pain from metastatic osseous lesions.

Bouchet LG, Bolch WE, Goddu SM, Howell RW, Rao DV.

J Nucl Med. 2000 Apr;41(4):682-7.

17.

Strontium and samarium therapy for bone metastases from prostate carcinoma.

Dickie GJ, Macfarlane D.

Australas Radiol. 1999 Nov;43(4):476-9.

PMID:
10901963
18.

186Re-HEDP for metastatic bone pain in breast cancer patients.

Lam MG, de Klerk JM, van Rijk PP.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S162-70. Epub 2004 Apr 29. Review.

PMID:
15118846
20.

[186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.

Minutoli F, Herberg A, Spadaro P, Restifo Pecorella G, Baldari S, Aricò D, Altavilla G, Baldari S.

Q J Nucl Med Mol Imaging. 2006 Dec;50(4):355-62.

Supplemental Content

Support Center